Three drugs for treating Alzheimer's disease - Aricept, Exelon and Reminyl - have been approved for use in the NHS by the National Institute for Clinical Excellence. But patients have to meet a number of strict criteria, including having been assessed by a specialist clinic as having a moderate or mild, rather than severe, condition.
More Home
NewsHelp accessing hsj.co.uk
We are aware that some of our users are experiencing problems accessing hsj.co.uk.
NewsImportant changes to your HSJ password
To protect your security as hsj.co.uk upgrades to a new platform, your existing password will no longer work.
CommentBonfire of financial penalties reaches cancer and RTT standards
Financial penalties are being lifted from high-profile standards including cancer and elective waiting times, so far without attracting much attention. How is this happening? And will it work, asks Rob Findlay
No comments yet